Clinical Microbiology Market New High Growth Revenue Sources - An Update

Global market size-

According to the new market research report Clinical Microbiology Market is estimated to be $3.9 billion in 2020 and projected to reach $5.3 billion by 2025, at a CAGR of 6.5%.

Technologies Impacting-

Technologies impacting Clinical microbiology market

• Polymerase Chain Reaction (PCR)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Microarraysand 34 more

New High Growth Revenue Sources  & Global market size-

New High Growth Revenue Sources for Clinical microbiology market

• Molecular Quality Controls Market - 0.17BN 10.2%
• Mycoplasma Testing Market - 0.69BN 9.7%
• Laboratory Proficiency Testing Market - 0.85BN 6.6%and 18 more

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367

Leading Players-

The major players operating in the microbiology testing/clinical microbiology market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.

Geographic Overview -

Geographically, the emerging Asian countries, such as China, India, South Korea, Taiwan, and Singapore, are offering high-growth opportunities for market players. The Asia Pacific market is projected to grow at the highest CAGR from 2020 to 2025. Government efforts to increase awareness related to genome-based infectious disease diagnosis; supportive regulations for the development and commercialization of advanced clinical microbiology products; rising healthcare expenditure; the increasing number of hospitals and clinical diagnostic laboratories in India and China; expanding research base across India, China, and Japan; and the rising incidence of infectious diseases are driving the growth of the APAC market.